NBIX

Neurocrine Biosciences
D

NBIX

136.940
USD
0.22
(0.16%)
مغلق
حجم التداول
45,913
الربح لكل سهم
5
العائد الربحي
-
P/E
41
حجم السوق
13,581,915,979
أصول ذات صلة الأخبار المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.